GlassScriptPhysician profile
Nathan B Fountain
NPI 1629147244
$45,248.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,710 · 2020: $17.33 · 2023: $32K · 2024: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Honoraria: $9,000 · Travel and Lodging: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,916.10 |
| Honoraria | $9,000.00 |
| Travel and Lodging | $604.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zevra Therapeutics INC | $10,104.59 | 2024 | |
| Biogen, INC. | $9,500.00 | 2023 | |
| H. Lundbeck A S | $9,000.00 | 2023 | |
| Eisai INC. | $8,750.00 | 2023 | |
| Ucb Sa | $5,166.10 | 2023 | |
| Medtronic USA, INC. | $2,667.00 | 2019 | |
| Supernus Pharmaceuticals, INC. | $43.36 | 2019 | |
| Livanova USA, INC. | $17.33 | 2020 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Fountain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.